0001572426-16-000158.txt : 20160222 0001572426-16-000158.hdr.sgml : 20160222 20160222194342 ACCESSION NUMBER: 0001572426-16-000158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160218 FILED AS OF DATE: 20160222 DATE AS OF CHANGE: 20160222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lismore Damian T. CENTRAL INDEX KEY: 0001560864 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 161446556 MAIL ADDRESS: STREET 1: 12270 WILKINS AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20852 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-02-18 0001618561 Nexvet Biopharma plc NVET 0001560864 Lismore Damian T. C/O NEXVET BIOPHARMA PLC UNIT 5, SRAGH TECHNOLOGY PARK, RAHAN RD TULLAMORE L2 R35 FR98 IRELAND 0 1 0 0 Chief Financial Officer Ordinary Shares 2016-02-18 4 P 0 5000 3.2199 A 18724 I Glenariff Superannuation Pty Ltd <Glenariff Super Fund A/C> Ordinary Shares 16000 D Ordinary Shares 14160 I By Spouse Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.19 to $3.29, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The reporting person and his spouse share voting and dispositive power with respect to these reported securities. /s/ Damian Lismore by Geraldine Farrell, Attorney-in-Fact 2016-02-22